PLZF restricts intestinal ILC3 function in gut defense

被引:0
|
作者
Yaru Xu
Huasheng Zhang
Shuai Wu
Jianyue Liu
Hongzhi Liu
Dongdi Wang
Youqin Zhang
Hongshen Niu
Xiaohui Su
Jiping Sun
Lei Shen
机构
[1] Shanghai Jiao Tong University School of Medicine,Shanghai Institute of Immunology, Department of Immunology and Microbiology, and Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education
[2] Shanghai Jiao Tong University School of Medicine,Shanghai Key Laboratory of Tumor Microenvironment and Inflammation
[3] Shanghai Jiao Tong University School of Medicine,Department of Neurosurgery, Center for Immune
来源
关键词
Biological sciences; Immunology; Innate immune cells; Innate lymphoid cells;
D O I
暂无
中图分类号
学科分类号
摘要
Group 3 innate lymphoid cells (ILC3s) play important roles in maintaining intestinal homeostasis by protecting the host from pathogen infections and tissue inflammation. The transcription factor PLZF (promyelocytic leukemia zinc finger), encoded by zinc finger BTB domain containing 16 (Zbtb16), is highly and transiently expressed in ILC precursors (ILCPs). However, the role of PLZF in regulating ILC3 development and function remains unknown. Here, we show that PLZF was specifically expressed in mature intestinal ILC3s compared with other ILC subsets. PLZF was dispensable for ILC3 development. However, PLZF deficiency in ILC3s resulted in increased innate interleukin-22 (IL-22) secretion and protection against gut infection and inflammation. Mechanistically, PLZF negatively regulated IL-22 expression by ILC3s in a cell-intrinsic manner by binding to the IL-22 promoter region for transcriptional repression. Together, our data suggest that PLZF restricts intestinal ILC3 function to regulate gut immune homeostasis.
引用
收藏
页码:379 / 388
页数:9
相关论文
共 50 条
  • [1] PLZF restricts intestinal ILC3 function in gut defense
    Xu, Yaru
    Zhang, Huasheng
    Wu, Shuai
    Liu, Jianyue
    Liu, Hongzhi
    Wang, Dongdi
    Zhang, Youqin
    Niu, Hongshen
    Su, Xiaohui
    Sun, Jiping
    Shen, Lei
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2023, 20 (04) : 379 - 388
  • [2] Trained ILC3 responses promote intestinal defense
    Serafini, Nicolas
    Jarade, Angelique
    Surace, Laura
    Goncalves, Pedro
    Sismeiro, Odile
    Varet, Hugo
    Legendre, Rachel
    Coppee, Jean-Yves
    Disson, Olivier
    Durum, Scott K.
    Frankel, Gad
    Di Santo, James P.
    [J]. SCIENCE, 2022, 375 (6583) : 859 - +
  • [3] ILC3 in Axial Spondyloarthritis: the Gut Angle
    Daniele Mauro
    Federica Macaluso
    Serena Fasano
    Riccardo Alessandro
    Francesco Ciccia
    [J]. Current Rheumatology Reports, 2019, 21
  • [4] ILC3 in Axial Spondyloarthritis: the Gut Angle
    Mauro, Daniele
    Macaluso, Federica
    Fasano, Serena
    Alessandro, Riccardo
    Ciccia, Francesco
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2019, 21 (07)
  • [5] Inflammation triggers ILC3 patrolling of the intestinal barrier
    Angélique Jarade
    Zacarias Garcia
    Solenne Marie
    Abdi Demera
    Immo Prinz
    Philippe Bousso
    James P. Di Santo
    Nicolas Serafini
    [J]. Nature Immunology, 2022, 23 : 1317 - 1323
  • [6] Microbiota engage a HDAC3 rheostat to shape ILC3 metabolism and function in the gut
    Jensen, Samantha N.
    Teng, Fei
    Alenghat, Theresa
    Lazar, Mitchell A.
    Sonnenberg, Gregory F.
    [J]. JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [7] Inflammation triggers ILC3 patrolling of the intestinal barrier
    Jarade, Angelique
    Garcia, Zacarias
    Marie, Solenne
    Demera, Abdi
    Prinz, Immo
    Bousso, Philippe
    Di Santo, James P.
    Serafini, Nicolas
    [J]. NATURE IMMUNOLOGY, 2022, 23 (09) : 1317 - +
  • [8] Paeoniae Decoction restores intestinal barrier dysfunction by promoting the interaction between ILC3 and gut flora
    Huang, Shaowei
    Ye, Qiujuan
    Wang, Anjiang
    Chen, Ye
    [J]. PHYTOMEDICINE, 2024, 132
  • [9] Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes
    Stojanovic, Ivana
    Saksida, Tamara
    Miljkovic, Dorde
    Pejnovic, Nada
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] ILC3 aggression
    Zoltan Fehervari
    [J]. Nature Immunology, 2016, 17 (3) : 229 - 229